← Back to front page
United States · Wires & real time · PR Newswire

NeuroPace Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into NeuroPace (NPCE)

Published by PR Newswire · United States 3 h ago
NeuroPace Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into NeuroPace (NPCE)
PR Newswire

Detailed summary

NeuroPace raised its 2026 revenue outlook on August 11, 2026, then cut it to $91-$92 million one quarter later. The investigation concerns potential federal securities law…

NeuroPace raised its 2026 revenue outlook on August 11, 2026, then cut it to $91-$92 million one quarter later. The investigation concerns potential federal securities law violations tied to those statements.

NEW YORK, Nov. 16, 2026 /PRNewswire/ -- NeuroPace, Inc. (NASDAQ: NPCE) shares fell over 37% on November 13, 2026, after the Company cut its full-year 2026 revenue guidance to $91-$92 million, one quarter after management raised that same outlook to $99.5-$101.5 million. If you lost money on NeuroPace stock, you are encouraged to submit your loss information now or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

On the August 11, 2026 second-quarter call, Chief Financial Officer Patrick Williams told investors: "We are increasing full-year total revenue guidance to a range of $99.5 million to $101.5 million, compared to our previous range of $99 million to $101 million." He added: "We expect our third quarter RNS revenue growth to be similar to our first half RNS growth rate of approximately 20% year-over-year." On the same call, Chief Executive Officer Joel Becker cited "continued momentum in the core RNS business and disciplined execution across the organization."

In its third-quarter report, NeuroPace disclosed revenue of $23.1 million. Total revenue declined 1.1% year over year. Management attributed the shortfall to three causes: a sales-force restructuring, disruptions at several large customer accounts, and the continuing effect of exiting the SEEG distribution business. Levi & Korsinsky is investigating whether NeuroPace may not have adequately disclosed these developments and whether potential securities law violations occurred.

Shareholders who lost money on NPCE can request a free review of their NeuroPace losses or call (212) 363-7500.

WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights…

Q: Who…

Q…

Opening of the article, excerpted from PR Newswire. To read the rest, open the article on the publisher's site.

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading